The global healthcare industry continues to witness significant advancements in anemia management and supportive therapies for chronic diseases. Erythropoietin stimulating agents have become an essential therapeutic option for patients suffering from anemia associated with chronic kidney disease, cancer treatments, and anti-retroviral therapies. Increasing prevalence of renal disorders and...